Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $11.8150 (3.55%) ($11.8150 - $11.8150) on Wed. Jan. 4, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.42% (three month average) | RSI | 65 | Latest Price | $11.8150(3.55%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX advances 1.4% a day on average for past five trading days. | Weekly Trend | BCRX advances 2.9% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) BND(20%) BLOK(16%) URA(16%) XLK(16%) VUG(14%) | Factors Impacting BCRX price | BCRX will decline at least -1.71% in a week (0% probabilities). SMH(-29%) ARKG(-25%) VIXM(-9%) SHY(-9%) GLD(-9%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.71% (StdDev 3.42%) | Hourly BBV | 1.4 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $11.4(3.64%) | 10 Day Moving Average | $11.24(5.12%) | 20 Day Moving Average | $11.05(6.92%) | To recent high | -16.9% | To recent low | 12.8% | Market Cap | $2.085b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |